Can Second Resection for pT1 Bladder Cancer be Avoided After Initial En-Bloc Resection With Negative Safety Margins
NCT05969964 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 370
Last updated 2024-10-30
Summary
The goal of this \[ Can second resection for pT1 bladder carcinoma be safely avoided after initial En-Bloc Resection with negative vertical and horizontal safety margins ? is to assess the impact of avoiding re TUR on Recurrence free survival, progression free survival and cancer specific survival in patients with pT1 bladder cancer treated with ERBT and intravesical BCG through a RCT.
Conditions
- Bladder Cancer Stage I
Interventions
- BEHAVIORAL
-
Avoid second resection after initial complete resection
Those patients diagnosed with pT1 after initial ERBT with negative vertical and horizontal safety margins won't undergo second look as endorsed by the guidelines.
Sponsors & Collaborators
-
Mansoura University
lead OTHER
Principal Investigators
-
Mahmoud Laymon, MD,MRCS · Urology &Nephrology Center, Mansoura University, Egypt
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-01
- Primary Completion
- 2025-08-31
- Completion
- 2025-12-31
Countries
- Egypt
Study Locations
More Related Trials
-
A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival
NCT03266900 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Can Four Weeks-check Cystoscopy and Urine Cytology After Primary Complete Resection of T1 Bladder Cancer Replace Repeat Biopsy?
NCT05167916 ·Status: UNKNOWN ·Phase: NA
-
Comprehensive Multiparametric Magnetic Resonance Imaging After Transurethral Resection of Non Muscle-invasive Bladder Tumor; Can it Replace Second Look Biopsy? A Prospective Study
NCT03914001 ·Status: UNKNOWN ·Phase: NA
-
Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial
NCT05146635 ·Status: UNKNOWN ·Phase: NA
-
Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade
NCT02992990 ·Status: UNKNOWN ·Phase: NA
-
En-Bloc Resection of Bladder Tumors
NCT04784507 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident
NCT03148158 ·Status: UNKNOWN
-
Bipolar Versus Mono-polar Needlescopic En Bloc TUR-BT
NCT04839029 ·Status: UNKNOWN ·Phase: NA
-
Impact of Time to Re-staging Transurethral Resection on Recurrence and Progression Rates
NCT04768894 ·Status: COMPLETED ·Phase: NA
-
Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial.
NCT04939194 ·Status: UNKNOWN ·Phase: PHASE3
-
Diagnostic Performance and Predictive Capacity of Immediate Urine Cytology After Transurethral Resection of Non-Muscle Invasive Bladder Cancer; A Prospective Study
NCT04194112 ·Status: COMPLETED ·Phase: NA
-
En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
NCT04235764 ·Status: RECRUITING
-
Transurethral Modified En Bloc Resection For Large Bladder Tumours.
NCT04081246 ·Status: RECRUITING ·Phase: NA
-
Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy.
NCT02438865 ·Status: COMPLETED ·Phase: PHASE2
-
Bladder Perforation Post-TURBT: Definition, Incidence and Natural HistoryStudy
NCT04129606 ·Status: UNKNOWN ·Phase: NA
-
Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer
NCT02716961 ·Status: UNKNOWN ·Phase: NA
-
Prospective Multicentric Evaluation of a Bladder Preservation Strategy
NCT01093066 ·Status: TERMINATED ·Phase: PHASE2
-
Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma
NCT07043790 ·Status: COMPLETED ·Phase: NA
-
En Bloc Bladder Tumor Resection: Prospective Randomized Study
NCT04712201 ·Status: RECRUITING ·Phase: NA
-
The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection
NCT06287541 ·Status: RECRUITING ·Phase: NA
-
A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer
NCT02951078 ·Status: UNKNOWN ·Phase: PHASE3
-
Thulium Laser En-bloc Resection of Primary Non-muscle Invasive Bladder Cancer
NCT06818799 ·Status: COMPLETED ·Phase: NA
-
Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
NCT00003640 ·Status: TERMINATED ·Phase: PHASE2
-
Oncological Outcomes of Different Patterns of Tumor Recurrence at First Evaluation After Bacillus Calmette-Guérin Induction Therapy for Intermediate and High Risk Non Muscle Invasive Bladder Cancer
NCT04319263 ·Status: COMPLETED ·Phase: NA
-
Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer
NCT05822934 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3